Brazzaville – Lower than 2% of the 690 million COVID-19 vaccine doses administered up to now globally have been in Africa, the place most nations acquired vaccines solely 5 weeks in the past and in small portions.
Forty-five African nations have acquired vaccines, 43 of them have begun vaccinations and practically 13 million of the 31.6 million doses delivered to date have been administered. The tempo of vaccine rollout is, nevertheless, not uniform, with 93% of the doses given in 10 nations.
Vaccine rollout preparedness, together with coaching of well being employees, prelisting precedence teams and coordination has helped some nations shortly attain a big proportion of the focused high-risk inhabitants teams corresponding to well being employees. The 10 nations which have vaccinated probably the most have used a minimum of 65% of their provides.
“Though progress is being made, many African nations have barely moved past the beginning line. Restricted shares and provide bottlenecks are placing COVID-19 vaccines out of attain of many individuals on this area,” mentioned Dr Matshidiso Moeti, the World Well being Group (WHO) Regional Director for Africa. “Honest entry to vaccines should be a actuality if we’re to collectively make a dent on this pandemic.”
As soon as delivered, vaccine rollout in some nations has been delayed by operational and monetary hurdles or logistical difficulties corresponding to reaching distant areas. WHO is supporting nations to deal with the challenges by reinforcing planning and coordination, advocating extra monetary sources in addition to organising efficient communications methods to handle vaccine hesitancy and misinformation.
The delays should not solely affecting vaccine supply to precedence targets however increasing vaccinations to the remainder of the inhabitants, a few of whom have expressed eagerness to obtain the doses. WHO set a goal to begin vaccinating well being employees and different precedence teams in all nations within the first 100 days of 2021.
“Africa is already taking part in COVID-19 vaccination catch-up, and the hole is widening. Whereas we acknowledge the immense burden positioned by the worldwide demand for vaccines, inequity can solely worsen shortage,” mentioned Dr Moeti. “Greater than a billion Africans stay on the margins of this historic march to beat the pandemic.”
By way of the COVAX Facility, 16.6 million vaccine doses – primarily AstraZeneca – have been delivered to African nations.
The WHO’s World Advisory Committee for Vaccine Security this week concluded that the hyperlink between the AstraZeneca vaccine and the incidence of uncommon blood clots is believable however not but confirmed. This follows the European Medicines Company’s announcement that uncommon blood clots must be listed as very uncommon side-effects of the vaccine.
Among the many virtually 200 million people who’ve acquired the AstraZeneca COVID-19 vaccine all over the world, circumstances of blood clots and low platelets is extraordinarily low.
The World Advisory Committee for Vaccine Security continues to assemble and evaluation additional knowledge whereas fastidiously monitoring the rollout of all COVID-19 vaccines. Primarily based on present data, WHO considers that the advantages drastically outweigh the dangers and that nations in Africa ought to proceed to vaccinate individuals with the AstraZeneca vaccine.
There have now been round 4.three million COVID-19 circumstances on the African continent and 114 000 individuals have died. For the previous two months, the area has seen a plateau of round 74 000 new circumstances per week. Nevertheless, Kenya is experiencing a 3rd wave and the epidemic is displaying an upward pattern in 14 different African nations, together with Ethiopia, Eritrea, Mali, Rwanda and Tunisia.
Dr Moeti spoke throughout a digital press convention at this time facilitated by APO Group. She was joined by Dr Abdelhakim Yahyane, Director of Inhabitants, Ministry of Well being, Morocco, and Mr Mohamed Malick Fall, UNICEF Regional Director for Jap and Southern Africa. Additionally readily available to reply questions have been Dr Salam Gueye, Director, Regional Emergency Preparedness and Response, WHO Regional Workplace for Africa, and Dr Richard Mihigo, Immunization and Vaccine Improvement Programme Coordinator, WHO Regional Workplace for Africa.
For Extra Info or to Request Interviews, Please contact:
Communications Marketing consultant
Tel: + 1 (682) 812 2306 (WhatsApp)
WHO Regional Workplace for Africa
Cell: +242 06 508 1009
— to reliefweb.int